Antibiotics for All?

Mass distribution of the antibiotic azithromycin has been shown to reduce under-5 mortality by 14% compared to the placebo.
 
But those promising results also raised big questions about the usefulness of mass deploying antibiotics, and whether it promotes antibiotic resistance.
 
One follow-up study in Tanzania found the drug did not trigger resistance—but researchers have several theories on why they didn't find an increase in resistance.
 
And while targeting only high-risk groups may have a greater effect per person, researchers found that it has a lesser impact on overall mortality.
 
One sure fire answer: More research. A countrywide study begins in Niger this summer.
 
CIDRAP

Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top